INCB9471 – CCR5 Antagonist for Treatment of HIV Infection, No Country
Key Data:
Drug (brand/generic)
INCB9471
Company/licensee
Incyte Corporation
Therapy class
CCR5 receptor antagonist
Product description
Blocks the CCR5 co-receptor on host CD4-T cells
Current indication
Treatment of HIV
Market sector
Antiifectives
Development status
Phase II
